Ashley McEvoy is Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson (J&J) and a member of the J&J Executive Committee. J&J Medical Devices comprises Orthopaedics, Surgery, Interventional, and Vision businesses, which includes 11 platforms that generate more than $1B in sales annually. Touching the lives of nearly half a billion patients every year, Ashley oversees the second largest MedTech company in the world—operating the #1 Orthopaedics, Surgery and Interventional Atrial Fibrillation businesses, as well as the #2 Vision business in the industry. The Medical Devices business sector has a comprehensive global presence, with 70,000 employees located in practically every region around the world. Building on J&J’s rich heritage in healthcare, science and technology, Ashley leads a team that continues to display the century plus Medical Devices pioneering spirit as they work to reimagine the future of health today by innovating across the continuum of patient care, prioritizing and modernizing health and promoting health equity.
Ashley inspires her team to relentlessly focus on creating meaningful innovation and medical interventions that are smarter, less invasive, and more personalized at a lower cost. Her disciplined approach to portfolio optimization has enabled Medical Devices to advance its strategy by continuously investing in the core businesses, while progressing areas of strategic importance with high growth potential. Since 2017, she and her team have invested over $10B in executing approximately 150 acquisitions and strategic partnerships to round out the Medical Devices portfolio and enhance its ability to meet patient and customer needs today and in the future. This strategic approach has doubled the value of the Medical Devices pipeline compared to 2018 and has shaped and advanced the sector’s focus on innovation, with acquisitions including Auris, Verb Surgical, and Orthotaxy. Additionally, Ashley has spearheaded the company’s entrance into robotics and digital surgery with the commercially available platform, MONARCH®, and novel data software systems like C-SATS and Visible Patient.
Ashley has been with Johnson & Johnson for more than 20 years and has served in leadership roles with increasing scope and responsibility in J&J’s Consumer and Medical Devices sectors. She is a passionate people and performance-based leader who has delivered above-market results for all four multi-billion-dollar, global companies that she has lead. Ashley is especially adept and accomplished at designing and executing turnaround strategies for mission critical businesses.
In 2006, Ashley co-led the integration of Pfizer Consumer Healthcare into McNeil, the largest acquisition Johnson & Johnson had done to date. She delivered above-market results for the company’s global over-the-counter (OTC) business, while advancing patient access through key innovations including the first-of-its-kind transition of Zyrtec to OTC status. In 2009, as the Worldwide President of Ethicon, Ashley ran the global wound management business and grew leadership share in sutures and hernia care while advancing critical, patient-centered innovations. She is a multifaceted leader who has been in and understands operating rooms around the world and has achieved significant success building consumer-facing brands. Ashley is also a proven architect of creating winning teams, strong innovation pipelines and future-forward business models.
Prior to her current role, Ashley was Company Group Chairman for Johnson & Johnson Vision and a member of the Medical Devices Management Committee. Ashley and her team redefined Johnson & Johnson’s competitive position in Eye Health, one of the largest and most underserved need areas in healthcare today. Ashley prioritized business transformation through digital technology, delivering world-class patient experiences in both online and offline environments. Under her leadership, the J&J Vision team consistently delivered above-market growth and established a robust cadence of product introductions, while developing new business models to meet changing market needs.
Ashley is a committed ally and advocate for racial and social justice inside and outside of Johnson & Johnson. She plays a vital leadership role in helping build a diverse workforce today and for the future by identifying opportunities to promote health equity and address racial and gender disparities in healthcare across Medical Devices. Ashley is also the executive sponsor of J&J’s Open & Out employee resource group which supports the LGBTQIA+ community globally. With her championship, this group has advanced Johnson & Johnson’s goal of having its workforce reflect the populations it serves, evolving educational materials to heighten awareness and understanding, and creating a safe, inclusive work environment for all.
Ashley’s expertise, accomplishments and impact on the healthcare industry have been recognized by numerous business and philanthropic organizations. She was recognized in Fortune magazine’s 2019 list of the “Most Powerful Women” and was named a “Woman of Achievement” in 2020 by the National Association of Female Executives. Most recently, Ashley was ranked #1 on the Top 25 Women Leaders in Medical Devices list by The Healthcare Technology Report. Ashley serves on the Boards of The Children’s Hospital of Philadelphia and The Children’s Hospital of Philadelphia Foundation, and on the Board of Directors for AdvaMed, the leading global trade association for advancing medical technology on behalf of patients.